Summary: Zhejiang Jingxin Pharmaceutical Company is mainly engaged in the manufacture and sale of chemical bulk drugs, chemical intermediates and finished preparations. Key products include cyclopropyl carboxylic acid, ciprofloxacin lactate, ciprofloxacin, ciprofloxacin hydrochloride, levofloxacin hydrochloride and enrofloxaxcin, among which the sales volume of ciprofloxacin and levofloxacin hydrochloride ranked No.1 in the domestic markets. In addition, its ciprofloxacin hydrochloride under the brand na ... more
The recent increase in the closing price of the company's shares over three consecutive trading sessions on 25, 26 Sept and 6 Oct 2008 represents a deviation of 15%, thus constituting an unusual
